Literature DB >> 3088043

Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

E J Bowie, L A Solberg, D N Fass, C M Johnson, G J Knutson, M L Stewart, L J Zoecklein.   

Abstract

Bone marrow from a normal male pig was transplanted into a related female pig with severe homozygous von Willebrand's disease (vWd). After engraftment the circulating leukocytes were of the male karyotype, and the platelets were strongly positive for von Willebrand factor (vWF) by indirect immunofluorescence. The average level of vWF was 1.96 U/dl and of ristocetin cofactor was 2.8 U/dl. The ear immersion bleeding time before transplantation was consistently more than 15 min and afterwards varied between 5 min and more than 15 min. Transfused vWF corrected the bleeding time at a level of 10 U/dl, which is lower than that required for a von Willebrand pig. We concluded that: the plasmatic compartment is only minimally replenished by the vWF from platelets and megakaryocytes; and the platelet vWF alone only partially corrects the abnormal tests of the hemostatic mechanism in severe vWd.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088043      PMCID: PMC329526          DOI: 10.1172/JCI112560

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.

Authors:  D N Fass; W J Brockway; C A Owen; E J Bowie
Journal:  Thromb Res       Date:  1976-03       Impact factor: 3.944

2.  Histocompatibility matching. V. A comparison of typing and mixed cultures in unrelated individuals.

Authors:  F H Bach; E Day; M L Bach; B A Myhre; D P Sengar; P I Terasaki
Journal:  Tissue Antigens       Date:  1971

3.  Factor VIII, a series of homologous oligomers and a complex of two proteins.

Authors:  J A van Mourik; B N Bouma; W T LaBruyère; S de Graaf; I A Mochtar
Journal:  Thromb Res       Date:  1974-01       Impact factor: 3.944

4.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

5.  Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.

Authors:  P M Mannucci; R Lombardi; R Bader; L Vianello; A B Federici; S Solinas; M G Mazzucconi; G Mariani
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

6.  Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.

Authors:  J D Olson; W J Brockway; D N Fass; M A Magnuson; E J Bowie
Journal:  Am J Clin Pathol       Date:  1975-02       Impact factor: 2.493

7.  Synthesis of von Willebrand factor by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

8.  Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.

Authors:  T R Griggs; W P Webster; H A Cooper; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  Tests of hemostasis in swine: normal values and values in pigs affected with von Willebrand's disease.

Authors:  E J Bowie; C A Owen; P E Zollman; J H Thompson; D N Fass
Journal:  Am J Vet Res       Date:  1973-11       Impact factor: 1.156

10.  Subcellular platelet factor VIII antigen and von Willebrand factor.

Authors:  R L Nachman; E A Jaffe
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  21 in total

1.  Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.

Authors:  S Kanaji; S A Fahs; Q Shi; S L Haberichter; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 2.  Platelet von Willebrand factor in inherited and acquired bleeding disorders.

Authors:  P M Mannucci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 3.  Animal models of hemophilia and related bleeding disorders.

Authors:  Jay N Lozier; Timothy C Nichols
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

4.  Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients.

Authors:  Kamil Bugała; Adam Mazurek; Krzysztof Gryga; Monika Komar; Grzegorz Kopeć; Jacek Musiał; Piotr Podolec; Carlo Perricone; Wojciech Płazak
Journal:  Clin Rheumatol       Date:  2018-04-20       Impact factor: 2.980

5.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 6.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

7.  Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.

Authors:  R B Levene; F M Booyse; J Chediak; T S Zimmerman; D M Livingston; D C Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 8.  The role of von Willebrand factor in thrombus formation.

Authors:  Zaverio M Ruggeri
Journal:  Thromb Res       Date:  2007-05-09       Impact factor: 3.944

Review 9.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

10.  Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.

Authors:  Walter H A Kahr; Richard W Lo; Ling Li; Fred G Pluthero; Hilary Christensen; Ran Ni; Nima Vaezzadeh; Cynthia E Hawkins; Andrew S Weyrich; Jorge Di Paola; Carolina Landolt-Marticorena; Peter L Gross
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.